Literature DB >> 9020057

p38 mitogen activated protein kinase regulates endothelial VCAM-1 expression at the post-transcriptional level.

A Pietersma1, B C Tilly, M Gaestel, N de Jong, J C Lee, J F Koster, W Sluiter.   

Abstract

The cytokine tumor necrosis factor (TNF) alpha was found to stimulate the p38 mitogen activated protein (MAP) kinase signalling cascade in human umbilical vein endothelial cells. TNFalpha increased the activity of the p38 substrate MAP kinase-activated-protein (MAPKAP) kinase 2 and the subsequent phosphorylation of the small heat shock protein Hsp27 about two to three fold. This stimulation was blocked almost completely by the specific p38 MAP kinase inhibitor SB203580. This inhibitor also suppressed the TNFalpha-induced surface expression of the endothelial adhesion molecule vascular cell adhesion molecule (VCAM)-1. In contrast, inhibition of p38 MAP kinase had no effect on the stimulated surface expression of the intercellular cell adhesion molecule (ICAM)-1. VCAM-1 mRNA accumulation induced by TNFalpha was not affected by SB203580, suggesting that the p38 MAP kinase signalling cascade regulates the endothelial expression of VCAM-1 at the post-transcriptional level.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9020057     DOI: 10.1006/bbrc.1996.5886

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  40 in total

1.  Functional CB1 cannabinoid receptors in human vascular endothelial cells.

Authors:  J Liu; B Gao; F Mirshahi; A J Sanyal; A D Khanolkar; A Makriyannis; G Kunos
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

Review 2.  Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets.

Authors:  D W Hommes; M P Peppelenbosch; S J H van Deventer
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

3.  Chronic exposure to arsenic and high fat diet induces sex-dependent pathogenic effects on the kidney.

Authors:  Yixian Zhang; Jamie L Young; Lu Cai; Yong Guang Tong; Lining Miao; Jonathan H Freedman
Journal:  Chem Biol Interact       Date:  2019-06-22       Impact factor: 5.192

Review 4.  The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis.

Authors:  G Schett; J Zwerina; G Firestein
Journal:  Ann Rheum Dis       Date:  2007-09-07       Impact factor: 19.103

5.  Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway.

Authors:  M Rincón; H Enslen; J Raingeaud; M Recht; T Zapton; M S Su; L A Penix; R J Davis; R A Flavell
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

Review 6.  Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis.

Authors:  Anthony Wayne Orr; Nicole E Hastings; Brett R Blackman; Brian R Wamhoff
Journal:  J Vasc Res       Date:  2009-10-22       Impact factor: 1.934

7.  A Novel ASK Inhibitor AGI-1067 Inhibits TLR-4-Mediated Activation of ASK1 by Preventing Dissociation of Thioredoxin from ASK1.

Authors:  Shuhui Zheng; Lingli Long; Yonghao Li; Yuxia Xu; Zhang Jiqin; Weidong Ji; Wang Min
Journal:  Cardiovasc Pharm Open Access       Date:  2015-02-26

8.  CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation.

Authors:  H Häcker; H Mischak; T Miethke; S Liptay; R Schmid; T Sparwasser; K Heeg; G B Lipford; H Wagner
Journal:  EMBO J       Date:  1998-11-02       Impact factor: 11.598

Review 9.  Ste20-related proline/alanine-rich kinase: a novel regulator of intestinal inflammation.

Authors:  Yutao Yan; Didier Merlin
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

10.  Dual specificity phosphatase 1 regulates human inducible nitric oxide synthase expression by p38 MAP kinase.

Authors:  Tuija Turpeinen; Riina Nieminen; Ville Taimi; Taina Heittola; Outi Sareila; Andrew R Clark; Eeva Moilanen; Riku Korhonen
Journal:  Mediators Inflamm       Date:  2011-04-19       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.